Business Insights: Page 5

Doctor indicted for $20.7M in Medicare fraud

By LabPulse.com staff writers

A federal grand jury in New Jersey indicted Dr. Alexander Baldonado for allegedly engaging in a scheme involving the submission of over $20.7 million in fraudulent claims to Medicare.

February 23, 2024

FDA grants accelerated approval to Iovance’s melanoma cell therapy

By LabPulse.com staff writers

The FDA granted accelerated approval to Iovance Biotherapeutics’ T-cell therapy treatment for unresectable or metastatic melanoma.

February 21, 2024

International consortium aims to develop precision approach for CVD

By Matt Limb

An international collaboration has begun to develop personalized treatments for patients with cardiovascular disease, combining genetic analysis and better integration of health data.

February 21, 2024

Intellia Therapeutics, ReCode Therapeutics to collaborate on genomic medicines for CF

By LabPulse.com staff writers

Gene-editing firm Intellia Therapeutics and biotech company ReCode Therapeutics have entered into a strategic collaboration aimed at developing genomic medicines for the treatment of cystic fibrosis (CF).

February 16, 2024

Freenome raises $254M in funding to advance cancer test pipeline

By LabPulse.com staff writers

Biotech firm Freenome has raised $254 million in new funding from new and existing investors to accelerate its pipeline of early detection cancer tests for its multiomics platform.

February 15, 2024

Invitae files for chapter 11 bankruptcy protection

By LabPulse.com staff writers

Following rumors of imminent bankruptcy, plummeting stock prices, and subsequent trading suspension and delisting on the New York Stock Exchange, Invitae has filed for chapter 11 bankruptcy protection.

February 14, 2024

Roche confirms product development team layoffs

By LabPulse.com staff writers

Roche has confirmed that it plans to lay off several hundred employees from its product development team but has not given specific details.

February 13, 2024

CorDx submits EUA application for COVID-19/influenza rapid test

By LabPulse.com staff writers

CorDx has submitted an Emergency Use Authorization (EUA) application for its CorDx TyFast Flu A/B & COVID-19 Multiplex Rapid Test to the U.S. Food and Drug Administration (FDA).

February 10, 2024

T2 Biosystems gets FDA nod to expand bacteria panel

By LabPulse.com staff writers

T2 Biosystems announced it received 510(k) clearance to add A. baumannii to its T2Bacteria Panel.

February 12, 2024

Invitae delisted on NYSE, trading suspended

By LabPulse.com staff writers

Amid a flurry of speculation about the firm’s debt and restructuring plans, Invitae’s stock fell to a precipitous low, prompting the NYSE to suspend trading of the stock and announce that it has begun the process of delisting the company.

February 7, 2024

NanoString Technologies files for Chapter 11 bankruptcy

By LabPulse.com staff writers

NanoString Technologies, along with some of its subsidiaries, initiated voluntary restructuring proceedings, filing for Chapter 11 bankruptcy protection in the U.S. Bankruptcy Court for the District of Delaware.

February 5, 2024

DermTech to lay off 30 employees, take further restructuring measures

By LabPulse.com staff writers

DermTech will lay off 30 employees and take additional restructuring measures to cut operating expenses, streamline operations, and focus its resources on revenue growth.

February 1, 2024

Previous Page

Page 5 of 177

Next Page